Back to search results

Surgical Pembro +/- Olaparib w TMZ for rGBM

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma · Recurrent Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Isabel Arrillaga-Romany, MD, PhD) · iarrillaga@mgh.harvard.edu · 617-724-8770
    Contact: Principal Investigator (Isabel Arrillaga-Romany, MD, PhD)

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Rafael A Vega, MD, PhD) · rvega@bidmc.harvard.edu · (617) 667-1665
    Contact: Principal Investigator (Rafael Majid, MD)

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Luis N Gonzalez Castro, MD) · lgonzalez-castro@partners.org · 617-732-7432
    Contact: Principal Investigator (Luis N Gonzalez Castro, MD)

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study leads

  • Luis N Gonzalez Castro, MD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)